It signals your brain youre full, slows down digestion, and helps regulate blood sugar
In STEP-1, 1,961 adults on weekly semaglutide lost an average of 14.9% of body weight over 68 weeks, compared with 2.4% on placebo
Are hypoxic chambers permitted
Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
However, people with MS who also have obesity or type 2 diabetes may be candidates for GLP-1 therapy, says Alan David Kaye, MD, PhD, a professor and the vice chair of research in the anesthesiology department at LSU Health in Shreveport, Louisiana
Emerging role of glp-1 agonists in obesity: a comprehensive review of randomised controlled trials